Phenomics Australia is developing a series of webinars from our team to give our users, collaborators, and the wider research community the opportunity to further their learning and stay up to date on some of the most exciting Phenomics Australia-enabled research.
To celebrate the exciting science being conducted with the assistance of Phenomics Australia the node’s resident experts will provide insights into important professional and technical areas including biobanking, genome engineering, disease modelling, genotyping, phenotyping, functional genomics, high-throughput screening, and pathology skills.
The first webinar of our series is:
High throughput RNA-Seq following CRISPR mediated gene suppression through the Monash Functional Genomics Platform. Watch the video here.
More to come!
Phenomics Australia Functional Genomics & High-throughput Screening
Through the Victorian Centre for Functional Genomics (VCFG) at the Peter MacCallum Cancer Centre, the Harry Perkins Institute of Medical Research (Perkins), and most recently through the ANU Centre for Therapeutic Discovery (ACTD, The John Curtin School of Medical Research, ANU) Monash University, and at the University of Adelaide (in partnership with SAHMRI), Phenomics Australia Functional Genomics and High-throughput screening services enable biomedical researchers Australia-wide with the ability to perform novel discovery-based screens using multiple platforms.
The facilities are staffed by experts and offer a range of access opportunities, from enabling researchers to be embedded in the facility and to be trained on appropriate equipment and fully supported by the team from assay concept design, screening, and analysis, through to full fee-for-service screening capacity. Through this collaborative approach, the Researcher always maintains control of their data through frequent discussion with the facility team.
By housing extensive liquid handling automation, high content imaging capabilities, and sophisticated plate reader instruments, the scale of a screen is entirely up to the researcher. All sites house an arrayed whole-genome human synthetic CRISPR library and have access through the VCFG to arrayed and pooled viral library screening resources. The ACTD and VCFG also house whole human genome siRNA SMARTpool arrayed libraries for RNAi screening. The VCFG also houses human miRNA, long non-coding RNA, and shRNA screening libraries, and a mouse whole-genome RNAi library. Through Compounds Australia, which houses Australia’s largest compound repository at Griffith University, all sites are able to offer compound screens at any scale.